Territory includes: Germany
Serving as a field-based extension of the Company’s Medical Affairs, the Medical Science Liaison (MSL) will support the Company’s Clinical Development program in Europe.
The MSL will build long term peer to peer relationships with clinical investigators, thought leaders, and other stakeholders within the Oncology community to deliver clinical, scientific, and technical education on the role of metastatic melanoma. The MSL will work full time to educate, analyze, and resolve issues with clinical research sites and investigators. The MSL will serve as a liaison between the Company, the clinical study sites and the clinical research associates (CRAs). The MSL will be responsible for identifying and conducting outreach to clinical investigators and site staff to develop relationships, support education and enrollment initiatives and represent the Company’s interests.